Affordable Access

Combined low-dose cytarabine, melphalan and mitoxantrone for older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome.

Authors
Type
Published Article
Journal
Anticancer research
Publication Date
Volume
27
Issue
4C
Pages
2635–2639
Identifiers
PMID: 17695426
Source
Medline
License
Unknown

Abstract

The present regimen was more effective and displayed similar safety, compared with low-dose ara-C alone.

Statistics

Seen <100 times